Abstract Gastrointestinal (GI) strictures are difficult to treat in a variety of disease processes. Currently. there are no Food and Drug Administration (FDA) approved drugs for fibrosis in the GI tract. One of the limitations to developing anti-fibrotic drugs has been the lack of a reproducible. https://herbsdailyes.shop/product-category/phosphatidylserine/